{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:32:24Z","timestamp":1793734344116,"version":"4.6.1"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271459"],"award-info":[{"award-number":["82271459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00415-025-13051-x","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T07:03:17Z","timestamp":1743836597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis"],"prefix":"10.1007","volume":"272","author":[{"given":"Wenyi","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"7","key":"13051_CR1","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/s2666-7568(24)00094-1","volume":"5","author":"J Zhu","year":"2024","unstructured":"Zhu J, Cui Y, Zhang J, Yan R, Su D, Zhao D et al (2024) Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev 5(7):e464\u2013e479. https:\/\/doi.org\/10.1016\/s2666-7568(24)00094-1","journal-title":"Lancet Healthy Longev"},{"issue":"5","key":"13051_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1474-4422(18)30499-x","volume":"18","author":"GN Collaborators","year":"2019","unstructured":"Collaborators GN (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x","journal-title":"Lancet Neurol"},{"issue":"1","key":"13051_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33\u201339. https:\/\/doi.org\/10.1001\/archneur.56.1.33","journal-title":"Arch Neurol"},{"issue":"12","key":"13051_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"5","key":"13051_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3238\/arztebl.2016.0061","volume":"113","author":"J Levin","year":"2016","unstructured":"Levin J, Kurz A, Arzberger T, Giese A, H\u00f6glinger GU (2016) The Differential Diagnosis and Treatment of Atypical Parkinsonism. Dtsch Arztebl Int 113(5):61\u201369. https:\/\/doi.org\/10.3238\/arztebl.2016.0061","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"13051_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90(8):870\u2013881. https:\/\/doi.org\/10.1136\/jnnp-2018-320106","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"13051_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","volume":"233","author":"A Petzold","year":"2005","unstructured":"Petzold A (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233(1\u20132):183\u2013198. https:\/\/doi.org\/10.1016\/j.jns.2005.03.015","journal-title":"J Neurol Sci"},{"issue":"11","key":"13051_CR8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","volume":"69","author":"S Hall","year":"2012","unstructured":"Hall S, \u00d6hrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F et al (2012) Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders. Arch Neurol 69(11):1445\u20131452. https:\/\/doi.org\/10.1001\/archneurol.2012.1654","journal-title":"Arch Neurol"},{"key":"13051_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fneur.2015.00091","volume":"6","author":"MK Herbert","year":"2015","unstructured":"Herbert MK, Aerts MB, Beenes M, Norgren N, Esselink RA, Bloem BR et al (2015) CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders. Front Neurol 6:91. https:\/\/doi.org\/10.3389\/fneur.2015.00091","journal-title":"Front Neurol"},{"issue":"11","key":"13051_CR10","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","volume":"86","author":"NK Magdalinou","year":"2015","unstructured":"Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K et al (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 86(11):1240\u20131247. https:\/\/doi.org\/10.1136\/jnnp-2014-309562","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"13051_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/wnl.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U et al (2017) Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930\u2013937. https:\/\/doi.org\/10.1212\/wnl.0000000000003680","journal-title":"Neurology"},{"issue":"10","key":"13051_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","volume":"72","author":"DC B\u00e4ckstr\u00f6m","year":"2015","unstructured":"B\u00e4ckstr\u00f6m DC, Eriksson Domell\u00f6f M, Linder J, Olsson B, \u00d6hrfelt A, Trupp M et al (2015) Cerebrospinal fluid patterns and the risk of future dementia in early. Incident Parkinson Disease JAMA Neurol 72(10):1175\u20131182. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1449","journal-title":"Incident Parkinson Disease JAMA Neurol"},{"issue":"2","key":"13051_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/wnl.0000000000004088","volume":"89","author":"D Alcolea","year":"2017","unstructured":"Alcolea D, Vilaplana E, Su\u00e1rez-Calvet M, Ill\u00e1n-Gala I, Blesa R, Clarim\u00f3n J et al (2017) CSF sAPP\u03b2, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology 89(2):178\u2013188. https:\/\/doi.org\/10.1212\/wnl.0000000000004088","journal-title":"Neurology"},{"issue":"2","key":"13051_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ane.13116","volume":"140","author":"R Constantinescu","year":"2019","unstructured":"Constantinescu R, Rosengren L, Eriksson B, Blennow K, Axelsson M (2019) Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. Acta Neurol Scand 140(2):147\u2013156. https:\/\/doi.org\/10.1111\/ane.13116","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"13051_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/jnnp-2018-320151","volume":"90","author":"E Jabbari","year":"2019","unstructured":"Jabbari E, Woodside J, Guo T, Magdalinou NK, Chelban V, Athauda D et al (2019) Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 90(7):768\u2013773. https:\/\/doi.org\/10.1136\/jnnp-2018-320151","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"13051_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","volume":"20","author":"M Khalil","year":"2024","unstructured":"Khalil M, Teunissen CE, Lehmann S, Otto M, Piehl F, Ziemssen T et al (2024) Neurofilaments as biomarkers in neurological disorders - towards clinical application. Nat Rev Neurol 20(5):269\u2013287. https:\/\/doi.org\/10.1038\/s41582-024-00955-x","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"13051_CR17","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","volume":"8","author":"YS Lin","year":"2018","unstructured":"Lin YS, Lee WJ, Wang SJ, Fuh JL (2018) Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. Sci Rep 8(1):17368. https:\/\/doi.org\/10.1038\/s41598-018-35766-w","journal-title":"Sci Rep"},{"issue":"1","key":"13051_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.27492","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer B, Zimmermann J, Sixel-D\u00f6ring F, Focke NK, Wicke T, Ebentheuer J et al (2019) Baseline predictors for progression 4 years after Parkinson\u2019s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa). Mov Disord 34(1):67\u201377. https:\/\/doi.org\/10.1002\/mds.27492","journal-title":"Mov Disord"},{"issue":"21","key":"13051_CR19","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.3390\/jcm10215085","volume":"10","author":"JH Chen","year":"2021","unstructured":"Chen JH, Chan L, Chung CC, Bamodu OA, Hong CT (2021) Blood neurofilament light chain in parkinson\u2019s disease: comparability between parkinson\u2019s progression markers initiative (ppmi) and asian cohorts. J Clin Med 10(21):5085. https:\/\/doi.org\/10.3390\/jcm10215085","journal-title":"J Clin Med"},{"key":"13051_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.805953","volume":"16","author":"Q Li","year":"2022","unstructured":"Li Q, Li Z, Han X, Shen X, Wang F, Bai L et al (2022) A panel of plasma biomarkers for differential diagnosis of Parkinsonian syndromes. Front Neurosci 16:805953. https:\/\/doi.org\/10.3389\/fnins.2022.805953","journal-title":"Front Neurosci"},{"key":"13051_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.909552","volume":"14","author":"P Zhang","year":"2022","unstructured":"Zhang P, Chen J, Cai T, He C, Li Y, Li X et al (2022) Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders. Front Aging Neurosci 14:909552. https:\/\/doi.org\/10.3389\/fnagi.2022.909552","journal-title":"Front Aging Neurosci"},{"key":"13051_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2022.06.004","volume":"101","author":"YY Wong","year":"2022","unstructured":"Wong YY, Wu CY, Yu D, Kim E, Wong M, Elez R et al (2022) Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis. Parkinsonism Relat Disord 101:119\u2013128. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.06.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"13051_CR23","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1212\/wnl.0000000000007179","volume":"92","author":"TM Marques","year":"2019","unstructured":"Marques TM, van Rumund A, Oeckl P, Kuiperij HB, Esselink RAJ, Bloem BR et al (2019) Serum NFL discriminates Parkinson disease from atypical parkinsonisms. Neurology 92(13):e1479\u2013e1486. https:\/\/doi.org\/10.1212\/wnl.0000000000007179","journal-title":"Neurology"},{"issue":"8","key":"13051_CR24","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/mds.28060","volume":"35","author":"DB Archer","year":"2020","unstructured":"Archer DB, Mitchell T, Burciu RG, Yang J, Nigro S, Quattrone A et al (2020) Magnetic resonance imaging and neurofilament light in the differentiation of Parkinsonism. Mov Disord 35(8):1388\u20131395. https:\/\/doi.org\/10.1002\/mds.28060","journal-title":"Mov Disord"},{"key":"13051_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2020.05.033","volume":"77","author":"S Mangesius","year":"2020","unstructured":"Mangesius S, Mariotto S, Ferrari S, Pereverzyev S Jr, Lerchner H, Haider L et al (2020) Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers. Parkinsonism Relat Disord 77:57\u201363. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.05.033","journal-title":"Parkinsonism Relat Disord"},{"key":"13051_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119975","volume":"565","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang J, Li Y, Chen X, Ye Q (2024) Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease. Clin Chim Acta 565:119975. https:\/\/doi.org\/10.1016\/j.cca.2024.119975","journal-title":"Clin Chim Acta"},{"issue":"12","key":"13051_CR27","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1002\/mds.28738","volume":"36","author":"I Schulz","year":"2021","unstructured":"Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R et al (2021) Systematic assessment of 10 biomarker candidates focusing on \u03b1-synuclein-related disorders. Mov Disord 36(12):2874\u20132887. https:\/\/doi.org\/10.1002\/mds.28738","journal-title":"Mov Disord"},{"issue":"1","key":"13051_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S, Mastrangelo A, Rossi M, Zenesini C et al (2021) Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. NPJ Parkinsons Dis 7(1):93. https:\/\/doi.org\/10.1038\/s41531-021-00232-4","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"13051_CR29","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/mds.28779","volume":"36","author":"WW Aamodt","year":"2021","unstructured":"Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D et al (2021) Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease. Mov Disord 36(12):2945\u20132950. https:\/\/doi.org\/10.1002\/mds.28779","journal-title":"Mov Disord"},{"issue":"11","key":"13051_CR30","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H et al (2020) Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov Disord 35(11):1999\u20132008. https:\/\/doi.org\/10.1002\/mds.28206","journal-title":"Mov Disord"},{"issue":"1","key":"13051_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson\u2019s disease. Lancet Neurol 5(1):75\u201386. https:\/\/doi.org\/10.1016\/s1474-4422(05)70285-4","journal-title":"Lancet Neurol"},{"issue":"8","key":"13051_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/14737175.2024.2372339","volume":"24","author":"L Angelini","year":"2024","unstructured":"Angelini L, Paparella G, Bologna M (2024) Distinguishing essential tremor from Parkinson\u2019s disease: clinical and experimental tools. Expert Rev Neurother 24(8):799\u2013814. https:\/\/doi.org\/10.1080\/14737175.2024.2372339","journal-title":"Expert Rev Neurother"},{"key":"13051_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","volume":"43","author":"A Galbiati","year":"2019","unstructured":"Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L (2019) The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med Rev 43:37\u201346. https:\/\/doi.org\/10.1016\/j.smrv.2018.09.008","journal-title":"Sleep Med Rev"},{"issue":"10","key":"13051_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","volume":"32","author":"P Eusebi","year":"2017","unstructured":"Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M et al (2017) Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 32(10):1389\u20131400. https:\/\/doi.org\/10.1002\/mds.27110","journal-title":"Mov Disord"},{"issue":"1","key":"13051_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12883-022-02558-9","volume":"22","author":"Y Huang","year":"2022","unstructured":"Huang Y, Huang C, Zhang Q, Shen T, Sun J (2022) Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity. BMC Neurol 22(1):39. https:\/\/doi.org\/10.1186\/s12883-022-02558-9","journal-title":"BMC Neurol"},{"issue":"4","key":"13051_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/jpd-223519","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ma L, Liang D, Song B, Chen J, Huang Y et al (2023) Neurofilament light protein predicts disease progression in idiopathic REM sleep behavior disorder. J Parkinsons Dis 13(4):485\u2013499. https:\/\/doi.org\/10.3233\/jpd-223519","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"13051_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16143","volume":"31","author":"S Franthal","year":"2024","unstructured":"Franthal S, Khalil M, Kern D, Gattermeyer L, Buchmann A, Katschnig-Winter P et al (2024) Elevated serum neurofilament light chain protein in patients with essential tremor. Eur J Neurol 31(2):e16143. https:\/\/doi.org\/10.1111\/ene.16143","journal-title":"Eur J Neurol"},{"issue":"3","key":"13051_CR38","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s12311-023-01583-9","volume":"23","author":"M Salinas","year":"2024","unstructured":"Salinas M, Salinas VH, McGurn M, Hernandez N, Louis ED (2024) Serum neurofilament light-chain concentrations in essential tremor: a case-control study. Cerebellum 23(3):951\u2013956. https:\/\/doi.org\/10.1007\/s12311-023-01583-9","journal-title":"Cerebellum"},{"issue":"6","key":"13051_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/s0895-4356(97)00049-8","volume":"50","author":"HC Bucher","year":"1997","unstructured":"Bucher HC, Guyatt GH, Griffith LE, Walter SD (1997) The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 50(6):683\u2013691. https:\/\/doi.org\/10.1016\/s0895-4356(97)00049-8","journal-title":"J Clin Epidemiol"},{"issue":"16","key":"13051_CR40","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/sim.1201","volume":"21","author":"T Lumley","year":"2002","unstructured":"Lumley T (2002) Network meta-analysis for indirect treatment comparisons. Stat Med 21(16):2313\u20132324. https:\/\/doi.org\/10.1002\/sim.1201","journal-title":"Stat Med"},{"key":"13051_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"5","key":"13051_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, Zeng XT, Lin L, Chu H et al (2020) Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods 11(5):641\u2013654. https:\/\/doi.org\/10.1002\/jrsm.1429","journal-title":"Res Synth Methods"},{"issue":"1","key":"13051_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41531-022-00431-7","volume":"8","author":"C Xiang","year":"2022","unstructured":"Xiang C, Cong S, Tan X, Ma S, Liu Y, Wang H et al (2022) A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):165. https:\/\/doi.org\/10.1038\/s41531-022-00431-7","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"13051_CR44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"13051_CR45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0272989x12455847","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE (2013) Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making 33(5):641\u2013656. https:\/\/doi.org\/10.1177\/0272989x12455847","journal-title":"Med Decis Making"},{"key":"13051_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-067731","volume":"376","author":"A Hodkinson","year":"2022","unstructured":"Hodkinson A, Tsimpida D, Kontopantelis E, Rutter MK, Mamas MA, Panagioti M (2022) Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. BMJ 376:e067731. https:\/\/doi.org\/10.1136\/bmj-2021-067731","journal-title":"BMJ"},{"issue":"7414","key":"13051_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"13051_CR48","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J Chandler","year":"2019","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch V (2019) Cochrane handbook for systematic reviews of interventions. Wiley, Hoboken"},{"issue":"1","key":"13051_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s1353-8020(00)00083-3","volume":"8","author":"B Holmberg","year":"2001","unstructured":"Holmberg B, Johnels B, Ingvarsson P, Eriksson B, Rosengren L (2001) CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes. Parkinsonism Relat Disord 8(1):23\u201331. https:\/\/doi.org\/10.1016\/s1353-8020(00)00083-3","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"13051_CR50","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/jnnp.2006.107326","volume":"78","author":"D de Jong","year":"2007","unstructured":"de Jong D, Jansen RW, Pijnenburg YA, van Geel WJ, Borm GF, Kremer HP et al (2007) CSF neurofilament proteins in the differential diagnosis of dementia. J Neurol Neurosurg Psychiatry 78(9):936\u2013938. https:\/\/doi.org\/10.1136\/jnnp.2006.107326","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"13051_CR51","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/acn3.290","volume":"3","author":"JC Rojas","year":"2016","unstructured":"Rojas JC, Karydas A, Bang J, Tsai RM, Blennow K, Liman V et al (2016) Plasma neurofilament light chain predicts progression in progressive supranuclear palsy. Ann Clin Transl Neurol 3(3):216\u2013225. https:\/\/doi.org\/10.1002\/acn3.290","journal-title":"Ann Clin Transl Neurol"},{"key":"13051_CR52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2018.06.018","volume":"56","author":"L Donker Kaat","year":"2018","unstructured":"Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K et al (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinsonism Relat Disord 56:98\u2013101. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"13051_CR53","doi-asserted-by":"publisher","first-page":"e1231","DOI":"10.1212\/wnl.0000000000005261","volume":"90","author":"LHH Meeter","year":"2018","unstructured":"Meeter LHH, Vijverberg EG, Del Campo M, Rozemuller AJM, Donker Kaat L, de Jong FJ et al (2018) Clinical value of neurofilament and phospho-tau\/tau ratio in the frontotemporal dementia spectrum. Neurology 90(14):e1231\u2013e1239. https:\/\/doi.org\/10.1212\/wnl.0000000000005261","journal-title":"Neurology"},{"issue":"1","key":"13051_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13195-018-0361-3","volume":"10","author":"RW Paterson","year":"2018","unstructured":"Paterson RW, Slattery CF, Poole T, Nicholas JM, Magdalinou NK, Toombs J et al (2018) Cerebrospinal fluid in the differential diagnosis of Alzheimer\u2019s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimers Res Ther 10(1):32. https:\/\/doi.org\/10.1186\/s13195-018-0361-3","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"13051_CR55","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00415-018-8893-9","volume":"265","author":"C Wilke","year":"2018","unstructured":"Wilke C, Bender F, Hayer SN, Brockmann K, Sch\u00f6ls L, Kuhle J et al (2018) Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study. J Neurol 265(7):1618\u20131624. https:\/\/doi.org\/10.1007\/s00415-018-8893-9","journal-title":"J Neurol"},{"issue":"10","key":"13051_CR56","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/jnnp-2019-320826","volume":"90","author":"A Jeppsson","year":"2019","unstructured":"Jeppsson A, Wikkels\u00f6 C, Blennow K, Zetterberg H, Constantinescu R, Remes AM et al (2019) CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. J Neurol Neurosurg Psychiatry 90(10):1117\u20131123. https:\/\/doi.org\/10.1136\/jnnp-2019-320826","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"13051_CR57","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/mds.27731","volume":"34","author":"S Lerche","year":"2019","unstructured":"Lerche S, Machetanz G, Wurster I, Roeben B, Zimmermann M, Pilotto A et al (2019) Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile. Mov Disord 34(7):1069\u20131073. https:\/\/doi.org\/10.1002\/mds.27731","journal-title":"Mov Disord"},{"issue":"11","key":"13051_CR58","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1212\/wnl.0000000000008088","volume":"93","author":"CH Lin","year":"2019","unstructured":"Lin CH, Li CH, Yang KC, Lin FJ, Wu CC, Chieh JJ et al (2019) Blood NfL: A biomarker for disease severity and progression in Parkinson disease. Neurology 93(11):e1104\u2013e1111. https:\/\/doi.org\/10.1212\/wnl.0000000000008088","journal-title":"Neurology"},{"issue":"3","key":"13051_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","volume":"76","author":"B Olsson","year":"2019","unstructured":"Olsson B, Portelius E, Cullen NC, Sandelius \u00c5, Zetterberg H, Andreasson U et al (2019) Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders. JAMA Neurol 76(3):318\u2013325. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3746","journal-title":"JAMA Neurol"},{"issue":"1","key":"13051_CR60","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1038\/s41598-020-66090-x","volume":"10","author":"C Delaby","year":"2020","unstructured":"Delaby C, Alcolea D, Carmona-Iragui M, Ill\u00e1n-Gala I, Morenas-Rodr\u00edguez E, Barroeta I et al (2020) Differential levels of neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders. Sci Rep 10(1):9161. https:\/\/doi.org\/10.1038\/s41598-020-66090-x","journal-title":"Sci Rep"},{"issue":"7","key":"13051_CR61","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/ene.14247","volume":"27","author":"A Fourier","year":"2020","unstructured":"Fourier A, Formaglio M, Kaczorowski F, Mollion H, Perret-Liaudet A, Sauvee M et al (2020) A combination of total tau and neurofilaments discriminates between neurodegenerative and primary psychiatric disorders. Eur J Neurol 27(7):1164\u20131169. https:\/\/doi.org\/10.1111\/ene.14247","journal-title":"Eur J Neurol"},{"issue":"7","key":"13051_CR62","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/mds.28056","volume":"35","author":"S Lerche","year":"2020","unstructured":"Lerche S, Wurster I, R\u00f6ben B, Zimmermann M, Machetanz G, Wiethoff S et al (2020) CSF NFL in a longitudinally assessed pd cohort: age effects and cognitive trajectories. Mov Disord 35(7):1138\u20131144. https:\/\/doi.org\/10.1002\/mds.28056","journal-title":"Mov Disord"},{"issue":"1","key":"13051_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-020-00385-5","volume":"15","author":"ASL Ng","year":"2020","unstructured":"Ng ASL, Tan YJ, Yong ACW, Saffari SE, Lu Z, Ng EY et al (2020) Utility of plasma neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson\u2019s disease. Mol Neurodegener 15(1):33. https:\/\/doi.org\/10.1186\/s13024-020-00385-5","journal-title":"Mol Neurodegener"},{"issue":"2","key":"13051_CR64","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/mds.27897","volume":"35","author":"LP Oosterveld","year":"2020","unstructured":"Oosterveld LP, Verberk IMW, Majbour NK, El-Agnaf OM, Weinstein HC, Berendse HW et al (2020) CSF or serum neurofilament light added to \u03b1-Synuclein panel discriminates Parkinson\u2019s from controls. Mov Disord 35(2):288\u2013295. https:\/\/doi.org\/10.1002\/mds.27897","journal-title":"Mov Disord"},{"issue":"1","key":"13051_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-020-00148-5","volume":"7","author":"M Andr\u00e9asson","year":"2021","unstructured":"Andr\u00e9asson M, Lagali N, Badian RA, Utheim TP, Scarpa F, Colonna A et al (2021) Parkinson\u2019s disease with restless legs syndrome-an in vivo corneal confocal microscopy study. NPJ Parkinsons Dis 7(1):4. https:\/\/doi.org\/10.1038\/s41531-020-00148-5","journal-title":"NPJ Parkinsons Dis"},{"key":"13051_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.717930","volume":"13","author":"S Canaslan","year":"2021","unstructured":"Canaslan S, Schmitz M, Villar-Piqu\u00e9 A, Maass F, Gmitterov\u00e1 K, Varges D et al (2021) Detection of cerebrospinal fluid neurofilament light chain as a marker for alpha-synucleinopathies. Front Aging Neurosci 13:717930. https:\/\/doi.org\/10.3389\/fnagi.2021.717930","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"13051_CR67","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3233\/jad-210342","volume":"82","author":"A Pilotto","year":"2021","unstructured":"Pilotto A, Imarisio A, Carrarini C, Russo M, Masciocchi S, Gipponi S et al (2021) Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies. J Alzheimers Dis 82(3):913\u2013919. https:\/\/doi.org\/10.3233\/jad-210342","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"13051_CR68","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41531-022-00384-x","volume":"8","author":"L Batzu","year":"2022","unstructured":"Batzu L, Rota S, Hye A, Heslegrave A, Trivedi D, Gibson LL et al (2022) Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):154. https:\/\/doi.org\/10.1038\/s41531-022-00384-x","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"13051_CR69","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","volume":"93","author":"L Chouliaras","year":"2022","unstructured":"Chouliaras L, Thomas A, Malpetti M, Donaghy P, Kane J, Mak E et al (2022) Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 93(6):651\u2013658. https:\/\/doi.org\/10.1136\/jnnp-2021-327788","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13051_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.parkreldis.2022.05.006","volume":"99","author":"Y Compta","year":"2022","unstructured":"Compta Y, Painous C, Soto M, Pulido-Salgado M, Fern\u00e1ndez M, Camara A et al (2022) Combined CSF \u03b1-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative Parkinsonisms: from bedside to bench, and back again. Parkinsonism Relat Disord 99:33\u201341. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.006","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13051_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-022-00967-z","volume":"14","author":"C Delaby","year":"2022","unstructured":"Delaby C, Estell\u00e9s T, Zhu N, Arranz J, Barroeta I, Carmona-Iragui M et al (2022) The A\u03b21-42\/A\u03b21-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A\u03b21-42 alone. Alzheimers Res Ther 14(1):20. https:\/\/doi.org\/10.1186\/s13195-022-00967-z","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"13051_CR72","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3233\/jpd-223182","volume":"12","author":"LL Gibson","year":"2022","unstructured":"Gibson LL, Pollak TA, Heslegrave A, Hye A, Batzu L, Rota S et al (2022) Plasma neurofilament light and p-tau181 and risk of psychosis in Parkinson\u2019s disease. J Parkinsons Dis 12(5):1527\u20131538. https:\/\/doi.org\/10.3233\/jpd-223182","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"13051_CR73","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00702-022-02470-z","volume":"129","author":"S Haji","year":"2022","unstructured":"Haji S, Sako W, Murakami N, Osaki Y, Izumi Y (2022) Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis. J Neural Transm (Vienna) 129(3):301\u2013309. https:\/\/doi.org\/10.1007\/s00702-022-02470-z","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"13051_CR74","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jnc.15601","volume":"161","author":"J Ren","year":"2022","unstructured":"Ren J, Pan C, Wang Y, Xue C, Lin H, Xu J et al (2022) Plasma \u03b1-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson\u2019s disease. J Neurochem 161(6):506\u2013515. https:\/\/doi.org\/10.1111\/jnc.15601","journal-title":"J Neurochem"},{"key":"13051_CR75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2022.07.007","volume":"102","author":"T Tokutake","year":"2022","unstructured":"Tokutake T, Kasuga K, Tsukie T, Ishiguro T, Shimohata T, Onodera O et al (2022) Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy. Parkinsonism Relat Disord 102:30\u201335. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.07.007","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"13051_CR76","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mds.28847","volume":"37","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cao B, Hou Y, Gu X, Wei Q, Ou R et al (2022) Neurofilament light chain predicts disease severity and progression in multiple system atrophy. Mov Disord 37(2):421\u2013426. https:\/\/doi.org\/10.1002\/mds.28847","journal-title":"Mov Disord"},{"issue":"12","key":"13051_CR77","doi-asserted-by":"publisher","first-page":"e1218","DOI":"10.1212\/wnl.0000000000207600","volume":"101","author":"M Assogna","year":"2023","unstructured":"Assogna M, Premi E, Gazzina S, Benussi A, Ashton NJ, Zetterberg H et al (2023) Association of choroid plexus volume with serum biomarkers, clinical features, and disease severity in patients with frontotemporal lobar degeneration spectrum. Neurology 101(12):e1218\u2013e1230. https:\/\/doi.org\/10.1212\/wnl.0000000000207600","journal-title":"Neurology"},{"issue":"8","key":"13051_CR78","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s40520-023-02452-5","volume":"35","author":"FF de Oliveira","year":"2023","unstructured":"de Oliveira FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, Matas SLA, Bertolucci PHF et al (2023) Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer\u2019s disease. Aging Clin Exp Res 35(8):1741\u20131752. https:\/\/doi.org\/10.1007\/s40520-023-02452-5","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"13051_CR79","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41531-023-00481-5","volume":"9","author":"Y Guo","year":"2023","unstructured":"Guo Y, Shen XN, Huang SY, Chen SF, Wang HF, Zhang W et al (2023) Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy. NPJ Parkinsons Dis 9(1):40. https:\/\/doi.org\/10.1038\/s41531-023-00481-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"13051_CR80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41531-023-00476-2","volume":"9","author":"S Lerche","year":"2023","unstructured":"Lerche S, Zimmermann M, Roeben B, Wurster I, Fries FL, Deuschle C et al (2023) Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD. NPJ Parkinsons Dis 9(1):38. https:\/\/doi.org\/10.1038\/s41531-023-00476-2","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"13051_CR81","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-023-03120-1","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Ou R, Li C, Hou Y, Zhang L, Wei Q et al (2023) Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: a prospective cohort study. BMC Med 21(1):420. https:\/\/doi.org\/10.1186\/s12916-023-03120-1","journal-title":"BMC Med"},{"key":"13051_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148271","volume":"1805","author":"S Mao","year":"2023","unstructured":"Mao S, Teng X, Li Z, Zu J, Zhang T, Xu C et al (2023) Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson\u2019s disease. Brain Res 1805:148271. https:\/\/doi.org\/10.1016\/j.brainres.2023.148271","journal-title":"Brain Res"},{"key":"13051_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.11.018","volume":"106","author":"K Oliveira Hauer","year":"2023","unstructured":"Oliveira Hauer K, Pawlik D, Leuzy A, Janelidze S, Hall S, Hansson O et al (2023) Performance of [(18)F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy. Parkinsonism Relat Disord 106:105226. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.11.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13051_CR84","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41531-023-00509-w","volume":"9","author":"F Paolini Paoletti","year":"2023","unstructured":"Paolini Paoletti F, Gaetani L, Bellomo G, Chipi E, Salvadori N, Montanucci C et al (2023) CSF neurochemical profile and cognitive changes in Parkinson\u2019s disease with mild cognitive impairment. NPJ Parkinsons Dis 9(1):68. https:\/\/doi.org\/10.1038\/s41531-023-00509-w","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"13051_CR85","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1007\/s00415-023-11741-y","volume":"270","author":"L Peng","year":"2023","unstructured":"Peng L, Wan L, Liu M, Long Z, Chen D, Yuan X et al (2023) Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study. J Neurol 270(9):4248\u20134261. https:\/\/doi.org\/10.1007\/s00415-023-11741-y","journal-title":"J Neurol"},{"issue":"2","key":"13051_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23246","volume":"37","author":"H Sa\u00e7mac\u0131","year":"2023","unstructured":"Sa\u00e7mac\u0131 H, \u00c7ak\u0131r M, \u00d6zcan SS (2023) Adropin and MOTS-c as new peptides: do levels change in neurodegenerative diseases and ischemic stroke? J Biochem Mol Toxicol 37(2):e23246. https:\/\/doi.org\/10.1002\/jbt.23246","journal-title":"J Biochem Mol Toxicol"},{"key":"13051_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106112","volume":"181","author":"XN Shen","year":"2023","unstructured":"Shen XN, Wu KM, Huang YY, Guo Y, Huang SY, Zhang YR et al (2023) Systematic assessment of plasma biomarkers in spinocerebellar ataxia. Neurobiol Dis 181:106112. https:\/\/doi.org\/10.1016\/j.nbd.2023.106112","journal-title":"Neurobiol Dis"},{"key":"13051_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106237","volume":"185","author":"D Urso","year":"2023","unstructured":"Urso D, Batzu L, Logroscino G, Ray Chaudhuri K, Pereira JB (2023) Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson\u2019s disease. Neurobiol Dis 185:106237. https:\/\/doi.org\/10.1016\/j.nbd.2023.106237","journal-title":"Neurobiol Dis"},{"issue":"6","key":"13051_CR89","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209818","volume":"103","author":"C Anastassiadis","year":"2024","unstructured":"Anastassiadis C, Martinez-Valbuena I, Vasilevskaya A, Thapa S, Hadian M, Morales-Rivero A et al (2024) CSF \u03b1-Synuclein Seed amplification assay in patients with atypical Parkinsonian disorders. Neurology 103(6):e209818. https:\/\/doi.org\/10.1212\/wnl.0000000000209818","journal-title":"Neurology"},{"key":"13051_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106978","volume":"123","author":"MG Bianco","year":"2024","unstructured":"Bianco MG, Cristiani CM, Scaramuzzino L, Sarica A, Augimeri A, Chimento I et al (2024) Combined blood neurofilament light chain and third ventricle width to differentiate progressive supranuclear palsy from Parkinson\u2019s disease: a machine learning study. Parkinsonism Relat Disord 123:106978. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106978","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"13051_CR91","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209418","volume":"102","author":"K Bolsewig","year":"2024","unstructured":"Bolsewig K, van Unnik A, Blujdea ER, Gonzalez MC, Ashton NJ, Aarsland D et al (2024) Association of plasma amyloid, p-tau, GFAP, and NFL with CSF, clinical, and cognitive features in patients with dementia with Lewy bodies. Neurology 102(12):e209418. https:\/\/doi.org\/10.1212\/wnl.0000000000209418","journal-title":"Neurology"},{"key":"13051_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.118784","volume":"558","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang Y, Tao Q, Lu P, Meng F, Zhuang L et al (2024) Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: a multicenter cohort study. Clin Chim Acta 558:118784. https:\/\/doi.org\/10.1016\/j.cca.2024.118784","journal-title":"Clin Chim Acta"},{"issue":"1","key":"13051_CR93","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/aian.aian_507_23","volume":"27","author":"S Dey","year":"2024","unstructured":"Dey S, Yelamanchi R, Mullapudi T, Holla VV, Kamble N, Mahale RR et al (2024) Association of Insulin-like growth factor-1 and neurofilament light chain in patients with progressive supranuclear palsy. Ann Indian Acad Neurol 27(1):40\u201345. https:\/\/doi.org\/10.4103\/aian.aian_507_23","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"13051_CR94","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/alz.13653","volume":"20","author":"P Diaz-Galvan","year":"2024","unstructured":"Diaz-Galvan P, Przybelski SA, Algeciras-Schimnich A, Figdore DJ, Lesnick TG, Schwarz CG et al (2024) Plasma biomarkers of Alzheimer\u2019s disease in the continuum of dementia with Lewy bodies. Alzheimers Dement 20(4):2485\u20132496. https:\/\/doi.org\/10.1002\/alz.13653","journal-title":"Alzheimers Dement"},{"issue":"10","key":"13051_CR95","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1007\/s00415-024-12647-z","volume":"271","author":"S Katzdobler","year":"2024","unstructured":"Katzdobler S, N\u00fcbling G, Klietz M, Fietzek UM, Palleis C, Bernhardt AM et al (2024) GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA). J Neurol 271(10):6991\u20136999. https:\/\/doi.org\/10.1007\/s00415-024-12647-z","journal-title":"J Neurol"},{"key":"13051_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12669-7","author":"A Pilotto","year":"2024","unstructured":"Pilotto A, Ashton NJ, Lupini A, Battaglio B, Zatti C, Trasciatti C et al (2024) Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson\u2019s disease. J Neurol. https:\/\/doi.org\/10.1007\/s00415-024-12669-7","journal-title":"J Neurol"},{"issue":"1","key":"13051_CR97","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12883-024-03642-y","volume":"24","author":"WY Qi","year":"2024","unstructured":"Qi WY, Sun Y, Guo Y, Tan L (2024) Associations of sleep disorders with serum neurofilament light chain levels in Parkinson\u2019s disease. BMC Neurol 24(1):147. https:\/\/doi.org\/10.1186\/s12883-024-03642-y","journal-title":"BMC Neurol"},{"issue":"3","key":"13051_CR98","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/alz.13560","volume":"20","author":"E Sanchez","year":"2024","unstructured":"Sanchez E, Wilkinson T, Coughlan G, Mirza S, Baril AA, Ramirez J et al (2024) Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: results from the ontario neurodegenerative disease research initiative. Alzheimers Dement 20(3):1753\u20131770. https:\/\/doi.org\/10.1002\/alz.13560","journal-title":"Alzheimers Dement"},{"issue":"7","key":"13051_CR99","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1002\/alz.13914","volume":"20","author":"NA Singh","year":"2024","unstructured":"Singh NA, Alnobani A, Graff-Radford J, Machulda MM, Mielke MM, Schwarz CG et al (2024) Relationships between PET and blood plasma biomarkers in corticobasal syndrome. Alzheimers Dement 20(7):4765\u20134774. https:\/\/doi.org\/10.1002\/alz.13914","journal-title":"Alzheimers Dement"},{"issue":"1","key":"13051_CR100","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13195-024-01502-y","volume":"16","author":"A Vrillon","year":"2024","unstructured":"Vrillon A, Bousiges O, G\u00f6tze K, Demuynck C, Muller C, Ravier A et al (2024) Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies. Alzheimers Res Ther 16(1):146. https:\/\/doi.org\/10.1186\/s13195-024-01502-y","journal-title":"Alzheimers Res Ther"},{"key":"13051_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106102","volume":"123","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wang Y, Wang J, Cai Y, Liu P, Liu S et al (2024) The role of peripheral inflammation-related biomarkers in distinguishing Parkinson\u2019s disease. Parkinsonism Relat Disord 123:106102. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106102","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"13051_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"A Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G (2013) Graphical tools for network meta-analysis in STATA. PLoS ONE 8(10):e76654. https:\/\/doi.org\/10.1371\/journal.pone.0076654","journal-title":"PLoS ONE"},{"issue":"8","key":"13051_CR103","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00415-020-09781-9","volume":"268","author":"S Cong","year":"2021","unstructured":"Cong S, Xiang C, Wang H, Cong S (2021) Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis. J Neurol 268(8):2703\u20132712. https:\/\/doi.org\/10.1007\/s00415-020-09781-9","journal-title":"J Neurol"},{"issue":"4","key":"13051_CR104","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3233\/jad-190615","volume":"72","author":"SY Wang","year":"2019","unstructured":"Wang SY, Chen W, Xu W, Li JQ, Hou XH, Ou YN et al (2019) Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis. J Alzheimers Dis 72(4):1353\u20131361. https:\/\/doi.org\/10.3233\/jad-190615","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"13051_CR105","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cerme\u00f1o JC et al (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76(9):1035\u20131048. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1534","journal-title":"JAMA Neurol"},{"issue":"7","key":"13051_CR106","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","volume":"143","author":"AR Gafson","year":"2020","unstructured":"Gafson AR, Barth\u00e9lemy NR, Bomont P, Carare RO, Durham HD, Julien JP et al (2020) Neurofilaments: neurobiological foundations for biomarker applications. Brain 143(7):1975\u20131998. https:\/\/doi.org\/10.1093\/brain\/awaa098","journal-title":"Brain"},{"issue":"2","key":"13051_CR107","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/brain\/awac328","volume":"146","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, D\u2019Anna L, Russo M, Steinacker P et al (2023) The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain 146(2):421\u2013437. https:\/\/doi.org\/10.1093\/brain\/awac328","journal-title":"Brain"},{"issue":"6","key":"13051_CR108","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/s0002-9440(10)65533-2","volume":"155","author":"K Spittaels","year":"1999","unstructured":"Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I et al (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155(6):2153\u20132165. https:\/\/doi.org\/10.1016\/s0002-9440(10)65533-2","journal-title":"Am J Pathol"},{"issue":"4","key":"13051_CR109","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/78078","volume":"25","author":"J Lewis","year":"2000","unstructured":"Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M et al (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25(4):402\u2013405. https:\/\/doi.org\/10.1038\/78078","journal-title":"Nat Genet"},{"issue":"16","key":"13051_CR110","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1523\/jneurosci.20-16-06021.2000","volume":"20","author":"H van der Putten","year":"2000","unstructured":"van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S et al (2000) Neuropathology in mice expressing human alpha-synuclein. J Neurosci 20(16):6021\u20136029. https:\/\/doi.org\/10.1523\/jneurosci.20-16-06021.2000","journal-title":"J Neurosci"},{"issue":"1","key":"13051_CR111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-022-00328-8","volume":"12","author":"I Frigerio","year":"2023","unstructured":"Frigerio I, Laansma MA, Lin CP, Hermans EJM, Bouwman MMA, Bol J et al (2023) Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson\u2019s disease dementia. Transl Neurodegener 12(1):3. https:\/\/doi.org\/10.1186\/s40035-022-00328-8","journal-title":"Transl Neurodegener"},{"issue":"9","key":"13051_CR112","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/jnnp-2021-328586","volume":"93","author":"S Koga","year":"2022","unstructured":"Koga S, Josephs KA, Aiba I, Yoshida M, Dickson DW (2022) Neuropathology and emerging biomarkers in corticobasal syndrome. J Neurol Neurosurg Psychiatry 93(9):919\u2013929. https:\/\/doi.org\/10.1136\/jnnp-2021-328586","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13051_CR113","doi-asserted-by":"publisher","unstructured":"Cook CN, Wu Y, Odeh HM, Gendron TF, Jansen-West K, Del Rosso G, et al. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci Transl Med. 2020;12(559). https:\/\/doi.org\/10.1126\/scitranslmed.abb3774","DOI":"10.1126\/scitranslmed.abb3774"},{"key":"13051_CR114","doi-asserted-by":"publisher","unstructured":"Reifschneider A, Robinson S, van Lengerich B, Gn\u00f6rich J, Logan T, Heindl S (2022), et al. Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency. Embo j. 41(4):e109108. https:\/\/doi.org\/10.15252\/embj.2021109108","DOI":"10.15252\/embj.2021109108"},{"issue":"1\u20132","key":"13051_CR115","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2015.03.041","volume":"352","author":"W Sako","year":"2015","unstructured":"Sako W, Murakami N, Izumi Y, Kaji R (2015) Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson\u2019s disease from atypical parkinsonism: evidence from a meta-analysis. J Neurol Sci 352(1\u20132):84\u201387. https:\/\/doi.org\/10.1016\/j.jns.2015.03.041","journal-title":"J Neurol Sci"},{"issue":"3","key":"13051_CR116","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10072-016-2783-7","volume":"38","author":"X Hu","year":"2017","unstructured":"Hu X, Yang Y, Gong D (2017) Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson\u2019s disease: a meta-analysis. Neurol Sci 38(3):407\u2013414. https:\/\/doi.org\/10.1007\/s10072-016-2783-7","journal-title":"Neurol Sci"},{"issue":"6","key":"13051_CR117","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1212\/cpj.0000000000001116","volume":"11","author":"E Angelopoulou","year":"2021","unstructured":"Angelopoulou E, Bougea A, Papadopoulos A, Papagiannakis N, Simitsi AM, Koros C et al (2021) CSF and circulating NfL as biomarkers for the discrimination of parkinson disease from atypical Parkinsonian syndromes: meta-analysis. Neurol Clin Pract 11(6):e867\u2013e875. https:\/\/doi.org\/10.1212\/cpj.0000000000001116","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"13051_CR118","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, Maia LF, Preische O, Schelle J, Apel A, Kaeser SA et al (2016) Neurofilament light chain in blood and csf as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron 91(1):56\u201366. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.018","journal-title":"Neuron"},{"issue":"7825","key":"13051_CR119","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B et al (2020) Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585(7825):464\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2317-6","journal-title":"Nature"},{"issue":"7933","key":"13051_CR120","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG et al (2022) Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature 610(7933):791\u2013795. https:\/\/doi.org\/10.1038\/s41586-022-05319-3","journal-title":"Nature"},{"issue":"1","key":"13051_CR121","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40035-023-00342-4","volume":"12","author":"M Schmitz","year":"2023","unstructured":"Schmitz M, Candelise N, Canaslan S, Altmeppen HC, Matschke J, Glatzel M et al (2023) \u03b1-Synuclein conformers reveal link to clinical heterogeneity of \u03b1-synucleinopathies. Transl Neurodegener 12(1):12. https:\/\/doi.org\/10.1186\/s40035-023-00342-4","journal-title":"Transl Neurodegener"},{"issue":"9","key":"13051_CR122","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00234-012-1009-9","volume":"54","author":"K Tsukamoto","year":"2012","unstructured":"Tsukamoto K, Matsusue E, Kanasaki Y, Kakite S, Fujii S, Kaminou T et al (2012) Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson\u2019s disease: evaluation by 3.0-T MR imaging. Neuroradiology 54(9):947\u2013955. https:\/\/doi.org\/10.1007\/s00234-012-1009-9","journal-title":"Neuroradiology"},{"issue":"Pt 7","key":"13051_CR123","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1093\/brain\/awt118","volume":"136","author":"SA Sajjadi","year":"2013","unstructured":"Sajjadi SA, Acosta-Cabronero J, Patterson K, Diaz-de-Grenu LZ, Williams GB, Nestor PJ (2013) Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases. Brain 136(Pt 7):2253\u20132261. https:\/\/doi.org\/10.1093\/brain\/awt118","journal-title":"Brain"},{"issue":"6","key":"13051_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066022","volume":"8","author":"Y Surova","year":"2013","unstructured":"Surova Y, Szczepankiewicz F, L\u00e4tt J, Nilsson M, Eriksson B, Leemans A et al (2013) Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography. PLoS ONE 8(6):e66022. https:\/\/doi.org\/10.1371\/journal.pone.0066022","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"13051_CR125","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.parkreldis.2004.10.014","volume":"11","author":"Y Tsuboi","year":"2005","unstructured":"Tsuboi Y, Dickson DW (2005) Dementia with Lewy bodies and Parkinson\u2019s disease with dementia: are they different? Parkinsonism Relat Disord 11(Suppl 1):S47-51. https:\/\/doi.org\/10.1016\/j.parkreldis.2004.10.014","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"13051_CR126","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12):1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"issue":"1","key":"13051_CR127","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/wnl.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100. https:\/\/doi.org\/10.1212\/wnl.0000000000004058","journal-title":"Neurology"},{"key":"13051_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577662","volume":"358","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Yang B, Wang F, Liu B, Li K, Yin K et al (2021) Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson\u2019s disease. J Neuroimmunol 358:577662. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577662","journal-title":"J Neuroimmunol"},{"issue":"9","key":"13051_CR129","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1007\/s00415-023-11785-0","volume":"270","author":"DG Park","year":"2023","unstructured":"Park DG, Kim JY, Kim MS, Kim MH, An YS, Chang J et al (2023) Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder. J Neurol 270(9):4393\u20134402. https:\/\/doi.org\/10.1007\/s00415-023-11785-0","journal-title":"J Neurol"},{"issue":"12","key":"13051_CR130","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.48593","volume":"5","author":"M Kolski","year":"2022","unstructured":"Fundaun J, Kolski M, Molina-\u00c1lvarez M, Baskozos G, Schmid AB (2022) Types and concentrations of blood-based biomarkers in adults with peripheral neuropathies: a systematic review and meta-analysis. JAMA Netw Open 5(12):e2248593. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.48593","journal-title":"JAMA Netw Open"},{"issue":"7","key":"13051_CR131","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/jamapsychiatry.2024.1030","volume":"81","author":"C Zhuo","year":"2024","unstructured":"Zhuo C (2024) Errors in numbers of participants in studies included in meta-analysis. JAMA Psychiat 81(7):738. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.1030","journal-title":"JAMA Psychiat"},{"key":"13051_CR132","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnagi.2016.00290","volume":"8","author":"D Li","year":"2016","unstructured":"Li D, Shen D, Tai H, Cui L (2016) Neurofilaments in CSF as diagnostic biomarkers in motor neuron disease: a meta-analysis. Front Aging Neurosci 8:290. https:\/\/doi.org\/10.3389\/fnagi.2016.00290","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"13051_CR133","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/jnnp-2018-319190","volume":"90","author":"SJ Martin","year":"2019","unstructured":"Martin SJ, McGlasson S, Hunt D, Overell J (2019) Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies. J Neurol Neurosurg Psychiatry 90(9):1059\u20131067. https:\/\/doi.org\/10.1136\/jnnp-2018-319190","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13051_CR134","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neubiorev.2019.04.014","volume":"102","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Xin Y, Meng S, He Z, Hu W (2019) Neurofilament light chain protein in neurodegenerative dementia: a systematic review and network meta-analysis. Neurosci Biobehav Rev 102:123\u2013138. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.04.014","journal-title":"Neurosci Biobehav Rev"},{"key":"13051_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.841898","volume":"13","author":"JD Sanchez","year":"2022","unstructured":"Sanchez JD, Martirosian RA, Mun KT, Chong DS, Llorente IL, Uphaus T et al (2022) Temporal patterning of neurofilament light as a blood-based biomarker for stroke: a systematic review and meta-analysis. Front Neurol 13:841898. https:\/\/doi.org\/10.3389\/fneur.2022.841898","journal-title":"Front Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13051-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T06:09:54Z","timestamp":1744956594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13051-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["13051"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13051-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"311"}}